Endarterectomy vs. Stenting in Asymptomatic Carotid Artery Stenosis

The comparative efficacy and safety of carotid stenting vs. endarterectomy in asymptomatic carotid stenosis patients remains controversial and, what is worse, consensus seems unlikely in the near future. Given the lack of definite evidence, several meta-analyzis and systematic reviews have been produced in an attempt to shed some light on this matter.

Enfermedad carotidea asintomática: ¿Endarterectomía o angioplastia?

This study included all controlled and randomized trials comparing both techniques in asymptomatic patients using a pre-specified protocol.

 

Five controlled studies met the inclusion criteria, adding up more than 3,000 patients.


Read also: New Strategies for the Femoropopliteal Artery”.


The pooled incidence of any periprocedural stroke (RR 1.84; CI 95%, 0.99–3.40), periprocedural nondisabling stroke (RR 1.95; CI 95%, 0.98 – 3.89) and any periprocedural stroke or death (RR 1.72; CI 95%, 0.95 – 3.11) show a tendency against stenting. This tendency was observed in periprocedural events, with no difference in stroke at long term (RR 1.24; CI 95%, 0.76 – 2.03) or with the composite of periprocedural stroke, death, MI or ipsilateral stroke at long term (RR 0.92; IC 95%, 0.70–1.21).

 

Conclusion

The best revascularization technique for patients with asymptomatic carotid stenosis continues to be a matter of debate, despite the higher incidence of periprocedural stroke against stenting seems to tilt the scales in favor of endarterectomy.

 

Editorial Comment

The estimated risk of ipsilateral stroke for asymptomatic patients with a ≥50% stenosis to the internal carotid artery is as low as 0.5 or 1% per year. Hence, in order to show the benefits of revascularization, if any, we would need long term follow up.


Read also: Diabetics’ Silent Ischemia Myth Busted”.


The best medical treatment should be prescribed to these patients, but randomized studies comparing stenting vs. endarterectomy were carried out mostly between 1980 and 2000. Without a shadow of a doubt, current medical treatments are highly superior to any medical treatment two decades old, which is why we should consider a third option to treat these patients, one that the original studies had not considered.

 

At present, there are two randomized studies in progress (SPACE-II y CREST-II) that will provide valuable data on the comparative safety and efficacy of the best medical treatment vs. stenting + the best medical treatment vs. endarterectomy + the best medical treatment.

 

Original title: Carotid Stenting Versus Endarterectomy for Asymptomatic Carotid Artery Stenosis. A Systematic Review and Meta-Analysis.

Reference: Paola Moresoli et al. Stroke. 2017 Aug;48(8):2150-2157.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....